Dr. Osarenren Ogbeide, MD

Dr. Ogbeide practices at Baptist Memorial Hospital-Union County in New Albany, Mississippi, part of Baptist Memorial Health Care.

Dr. Ogbeide's NPI, 1952375156, was assigned on February 14, 2006. Dr. Ogbeide holds Tennessee license 768803.

Dr. Ogbeide's primary practice is Baptist Memorial Hospital-Union County, at 200 Hwy 30 West, New Albany, MS 38652 in Union County. The practice phone is (662) 538-7631.

Dr. Ogbeide's primary practice is Baptist Memorial Hospital-Union County in New Albany, Mississippi, part of Baptist Memorial Health Care. Dr. Ogbeide is also affiliated with Baptist Memorial Hospital-Memphis. The medical group on file is Baptist Memorial Hospital-Union County. Dmand AI also links Dr. Ogbeide to 3 more hospitals, 5 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ogbeide practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ogbeide's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Ogbeide's licenses on file in 3 states: Tennessee, Arkansas and Mississippi.

CMS data shows 1,585 Medicare services from Dr. Ogbeide across 8 procedure codes in 2024, for 405 Medicare patients. Medicare paid $121,289 for them.

CMS counts 405 Medicare patients who saw Dr. Ogbeide in 2024. The largest group is 65 to 74, with 156 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ogbeide's median patient age at 74, with 59% women.

In 2024, Dr. Ogbeide wrote 908 Medicare Part D claims for 132 patients. 78% of them were for generic drugs. CMS names the drug for 664 of them, across 25 drugs with 11 or more claims each, at $1,105,398 in total drug cost. In 2023, CMS named 314 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Ogbeide for performance year 2024, reported as part of a group. Dr. Ogbeide accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ogbeide as offering telehealth.

Dmand AI links 6 papers to Dr. Ogbeide, published from 2020 to 2025. Dr. Ogbeide has published most often in Cureus. Dr. Ogbeide's most frequent co-authors are Steve Biko Otieno, MD, PhD, Daniel J. George, MD and Pooja Sona Jagadish, MD.

Dmand AI links Dr. Ogbeide to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. Open Payments lists research payments to Dr. Ogbeide that name 1 trial.

CMS Open Payments shows 146 general payments to Dr. Ogbeide from 34 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 60% of the total. Gilead Sciences, Inc. paid the most, $7,355. It also lists 1 research payment totaling $34 in 2025, naming 1 clinical trial.